Security key
92941V209
- Security type / class
- Equity / COM
- Total 13F shares
- 51,488
- Total 13F value
- $29,868
- Share change
- -680
- SEC-reported price per share
- $0.57
- Number of holders
- 2
- Value change
- -$228
- Number of sells
- 1
Report period
Q4 2025
Institutions
2
Top holders
2
VYNE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Yarrow Bioscience, Inc. SEC filings
Yarrow Bioscience, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92941V209
Recent filing periods:
Ownership snapshot
Top reported holders of VYNE - VYNE THERAP. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AI Biotechnology LLC
Disclosed value leader
AI Biotechnology LLC
Comparable rows
0/15
Latest evidence
12 Dec 2025
3/4/5
13F
Highest disclosed value: $2,545,814
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
AI Biotechnology LLC has the largest disclosed position value at $2.55M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AI Biotechnology LLC's linked filing trail.
Disclosed position value
Top 5
AI Biotechnology LLC
$2.55M
BAKER BROS. ADVISORS LP
$285.2K
Andrew Saik
$265.5K
Matthew T. Wiley
$249.1K
ACORN CAPITAL ADVISORS, LLC
$199.4K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AI Biotechnology LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$2,545,814
1,116,585 shares
|
— | 01 Nov 2023 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$285,203
851,353 shares
|
— | 30 Sep 2025 |
| Andrew Saik |
3/4/5
Chief Financial Officer
|
—
denominator unverified
|
$265,547
116,468 shares
|
— | 28 May 2021 |
| Matthew T. Wiley |
3/4/5
Chief Commercial Officer
|
—
denominator unverified
|
$249,081
109,246 shares
|
— | 30 Jun 2021 |
| ACORN CAPITAL ADVISORS, LLC |
13F
Company
|
—
denominator unverified
|
$199,434
586,572 shares
|
— | 30 Sep 2025 |
| Shay Capital LLC |
13F
Company
|
—
denominator unverified
|
$165,013
492,577 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
51,488
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
3
Q4 2025 holders
2
Holder diff
-1
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend